Compass Pathways reports positive second Phase 3 trial for COMP360 in treatment-resistant depression
Compass Pathways has reported that its second pivotal Phase 3 [...]
FundaMental Pharma GmbH will present new preclinical data on its [...]
Compass Pathways has reported that its second pivotal Phase 3 [...]
FundaMental Pharma GmbH will present new preclinical data on its [...]